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Enterohaemorrhagic Escherichia coli (EHEC) is a major foodborne pathogen and tightly adheres to
human colonic epithelium by forming attaching/effacing lesions. To reach the epithelial surface,
EHEC must penetrate the thick mucus layer protecting the colonic epithelium. In this study, we
investigated how EHEC interacts with the intestinal mucus layer using mucin‐producing
LS174T colon carcinoma cells and human colonic mucosal biopsies. The level of EHEC binding
and attaching/effacing lesion formation in LS174T cells was higher compared to mucin‐deficient
colon carcinoma cell lines, and initial adherence was independent of the presence of flagellin,
Escherichia coli common pilus, or long polar fimbriae. Although EHEC infection did not affect gene
expression of secreted mucins, it resulted in reduced MUC2 glycoprotein levels. This effect was
dependent on the catalytic activity of the secreted metalloprotease StcE, which reduced the inner
mucus layer and thereby promoted EHEC access and binding to the epithelium in vitro and ex vivo.
Given the lack of efficient therapies against EHEC infection, StcE may represent a suitable target
for future treatment and prevention strategies.
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Enterohaemorrhagic Escherichia coli (EHEC) is a major foodborne path-
ogen in the developed world and affects mainly young children and
the elderly (Croxen et al., 2013). Most infections are caused by serotype
O157:H7 strains (Gould et al., 2013). In addition to causing diarrhoea
and haemorrhagic colitis, EHEC infection can result in life‐threatening
haemolytic uraemic syndrome (HUS), which is the main cause of acute
kidney failure in children in western countries and can lead to lifelong
renal and neurological impairment (Trachtman, Austin, Lewinski, &
Stahl, 2012). Notably, there is currently no specific treatment againstTech, Université Paris‐Saclay,
UK
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wileyoEHEC infection andHUS, and the use of antibiotics is not recommended
due to increased risk of developing HUS (Freedman et al., 2016).
After entering the human gut, EHEC binds to the intestinal epithe-
lium by adhesins such as fimbriae, pili or flagella (McWilliams & Torres,
2014). This initial recognition step is then followed by the formation of
firm attaching/effacing (A/E) lesions mediated by a type III secretion
system. In particular, the bacterial translocated intimin receptor is
injected into the host cell and becomes exposed on the cell membrane.
Subsequently, the EHEC outer membrane protein intimin binds to
translocated intimin receptor leading to intimate bacterial attachment
and initiating further signalling events within the host cell, which ulti-
mately result in actin polymerisation and pedestal formation (Stevens
& Frankel, 2014). Although EHEC A/E lesions have not been observed
clinically, ex vivo culture of human intestinal biopsies indicates EHECcense, which permits use, distribution and reproduction in any medium, provided
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2 of 10 HEWS ET AL.A/E lesion formation in the distal small intestine and colon (Chong
et al., 2007; Lewis, Cook, Tighe, & Schüller 2015).
Before adhering to the intestinal epithelium, EHEC must penetrate
the mucus layer, which acts as a physicochemical barrier and protects
the underlying epithelium from pathogens and foreign antigens. In the
colon, the mucus layer is around 400 μm thick and formed of two layers
(Johansson et al., 2014; McGuckin, Lindén, Sutton, & Florin 2011).
Whereas the inner layer is dense, firmly attached to the epithelium, and
virtually free of bacteria, the outer layer is loose, easily penetrable, and
densely colonised by the gut microbiota (Johansson et al., 2008). The
mucus layer is comprised of mucin glycoproteins secreted by epithelial
goblet cells (McGuckin et al., 2011). Around 20 mucins have been identi-
fied so far with the majority bound to the cell surface forming the glyco-
calyx. In contrast, gel‐forming mucin glycoproteins are secreted from
goblet cell granules and oligomerize into complex macromolecular struc-
tures incorporatingwater and thereby forming the inner and outermucus
layer (Juge, 2012; McGuckin et al., 2011). In the human intestine, MUC2
is the major secreted mucin of the mucus layer (Johansson et al., 2008).
Although the interaction of EHEC with the intestinal epithelium
has been intensely studied, its relationship with the mucus layer
remains largely unknown. In this study, we have investigated EHEC
binding and its effect on the mucus layer in mucus‐producing human
intestinal epithelial cell lines and mucosal biopsy samples.FIGURE 1 EHEC binding to mucus‐producing LS174T and mucus‐
deficient HT‐29 and Caco‐2 cells. (a) Immunofluorescence staining
for MUC2 (green) and cell nuclei (blue). Bar =10 μm. (b) Adherence of
EHEC TUV 93–0, 85–170 and Sakai after 1 hr of infection. Adhesion
was determined by counting colony‐forming units and is expressed as
percentage of cell‐bound bacteria relative to the inoculum.
***p < 0.001 versus Caco‐2 and HT‐29 cells2 | RESULTS
2.1 | EHEC adherence to mucus‐producing and
mucus‐deficient intestinal epithelial cells
To determine EHEC binding to different colon carcinoma cell lines,
colonocyte‐derived HT‐29 and Caco‐2 and goblet cell‐derived LS174T
cells were chosen. As shown in Figure 1a, only LS174T cells produced
MUC2, whereas no specific staining could be detected for HT‐29 and
Caco‐2 cells. Interestingly, binding of all EHEC strains tested (TUV 93‐
0, 85‐170, and Sakai) was significantly higher in LS174T cells compared
to Caco‐2 and HT‐29 cells after 1 hr of infection (Figure 1b).
We next examined which adhesins were involved in binding to
mucus‐deficient Caco‐2 and mucus‐producing LS174T cells. Infections
were performed with isogenic EHEC deletion mutants in intimin (Δeae),
E. coli common pilus (Δecp), long polar fimbriae (ΔlpfA1), and flagellin
(ΔfliC). As no significant differences in binding were detected after
1 hr of infection (Figure S1), the incubation period was prolonged to
3 hr to allow sufficient time for expression of adherence factors.
Whereas none of the adhesins tested significantly affected EHEC bind-
ing to Caco‐2 cells, increased binding to LS174T cells was observed in
the absence of flagellin (Figure 2a). In addition, the intimin‐negative
mutant showed reduced binding to LS174T cells, although this did not
reach significance. Subsequent immunofluorescence staining to detect
actin pedestals demonstrated EHEC A/E lesion formation in LS174T
but not in Caco‐2 cells after 3 hr of infection. As expected, EHEC Δeae
did not form A/E lesions in either cell line (Figure 2b). No pedestal
formation was observed in LS174T or Caco‐2 cells after 1 hr (data not
shown), and wild‐type EHEC demonstrated actin recruitment in Caco‐2
cells after 6 hr of infection (Figure 2b).2.2 | Influence of EHEC infection on mucus
production
In order to determine the effect of EHEC infection on mucus expres-
sion, LS174T cells were incubated with EHEC for up to 6 hr, and gene
expression of the two major secreted mucins, MUC2 and MUC5AC,
was examined by quantitative reverse transcription polymerase chain
reaction (qPCR). No significant changes were observed in EHEC‐
infected versus non‐infected cells (Figure 3a). In contrast, immunofluo-
rescence staining demonstrated significantly decreased MUC2 protein
levels after EHEC infection (Figure 3b,c). Counterstaining of cell nuclei
with 4',6‐diamidino‐2‐phenylindole (DAPI) confirmed that this was not
due to cell detachment (Figure 3b). In addition, MUC5AC was only pro-
duced by a small subset of cells, and staining intensity was not influ-
enced by EHEC infection (Figure 3d,e).2.3 | StcE decreases MUC2 protein levels and
enhances EHEC binding to colonic epithelium
Previous studies have identified a secreted EHEC metalloprotease
(StcE) with mucinase activity for human saliva (Grys, Siegel, Lathem,
& Welch, 2005). In order to investigate whether StcE affected intesti-
nal MUC2 levels during EHEC infection, we generated an isogenic stcE
FIGURE 2 Involvement of EHEC adhesins in
binding to Caco‐2 and LS174T cells. (a)
Adherence of wild‐type (wt) and adhesin‐
deficient EHEC strains after 3 hr of infection.
Adhesion was determined by colony‐forming
unit counting and is expressed as percentage
of cell‐bound bacteria relative to the inoculum.
***p < 0.001 versus wt. (b) Fluorescent actin
staining to identify A/E lesion formation.
Caco‐2 and LS174T cells were infected with
EHEC 85‐170 wt or Δeae for 3 or 6 hr (Caco‐2
for 6 hr) and stained for actin (green) and E. coli
(red). Inserts in top right corner show enlarged
image areas containing EHEC bacteria with
and without actin pedestals (LS174T wt and
Δeae, respectively). Bar = 5 μm
FIGURE 3 Influence of EHEC infection on
mucin expression. LS174T cells were infected
with TUV 93‐0 or left non‐infected (NI) for up
to 6 hr. (a) MUC2 and MUC5AC gene
expression was determined by qPCR, and
mRNA levels in infected cells are indicated as
fold changes relative to NI controls. (b) MUC2
and (d) MUC5AC protein expression was
evaluated by immunofluorescence staining. (b)
Cell nuclei were counterstained with DAPI,
and images are shown as separate
monochrome panels. Bars =50 μm. (c) MUC2
and (e) MUC5AC staining was quantified by
integrated density measurement. *p < 0.05,
***p < 0.001 versus NI
HEWS ET AL. 3 of 10deletion mutant in strain TUV 93‐0 by Lambda Red recombination. As
shown in Figure 4a and b, deletion of stcE significantly impaired reduc-
tion of MUC2 levels in EHEC‐infected LS174T cells. This was restored
to wild‐type levels after complementation with StcE (Figure 4a,b). Incontrast, complementation with catalytically inactive StcE (E447D)
did not exhibit any effect, and MUC2 levels were comparable to those
of the deletion mutant (Figure 4a,b). In addition to immunofluores-
cence staining, StcE‐dependent MUC2 reduction was confirmed by
FIGURE 4 EHEC StcE reduces mucin levels
and promotes A/E lesion formation on LS174T
cells. Cells were infected with wild‐type TUV
93‐0 (wt), an isogenic stcE mutant (ΔstcE),
ΔstcE complemented with wild‐type (comp),
or catalytically inactive StcE (inact), or left
non‐infected (NI) for (a–d) 6 hr or (e) 3 hr. (a)
MUC2 expression was determined by
immunofluorescence staining, bar = 5 μm or (c)
agarose gel electrophoresis and Western
blotting and quantified by integrated density
measurement (b and d, respectively). Means
with different letters are significantly different
(p < 0.001 for b, p < 0.01 for d). n = 2 in
duplicate for c and d. (e) A/E lesion formation
was assessed by immunofluorescence staining
and expressed as percentage of bacteria
associated with actin pedestals relative to the
total number of adherent bacteria, **p < 0.01,
*p < 0.05
4 of 10 HEWS ET AL.sodium dodecyl sulfate (SDS)‐agarose gel electrophoresis of cell
lysates and subsequent Western blotting with MUC2‐specific antibod-
ies (Figure 4c,d). We further determined whether decreased MUC2
levels facilitated EHEC access and binding to the epithelium and quan-
tified the number of total adherent bacteria (binding to mucus layer
and epithelium) and bacteria associated with actin pedestals (binding
to epithelium only). Whereas similar numbers of wild‐type, ΔstcE and
complemented EHEC were associated with LS174T monolayers, a sig-
nificant reduction in actin pedestal formation was observed with the
ΔstcE mutant (Figure 4e).
To confirm the effect of StcE on mucus production and EHEC
adherence in a biologically relevant model, we performed in vitro organ
culture (IVOC) of human colonic biopsy samples (Lewis et al., 2015).
Whereas the epithelium was covered by a firmly adherent inner mucus
layer in non‐infected tissue samples, diminished MUC2 levels and
exposure of underlying crypt‐associated goblet cells was evident after
8 hr of EHEC infection (Figure 5a,b). In contrast, incubation with EHEC
ΔstcE resulted only in marginal disruption of the mucus layer leading to
the appearance of “dark holes” devoid of MUC2 staining. Attenuated
mucus reduction by EHEC ΔstcE was restored to wild‐type levels after
complementation with wild‐type but not catalytically inactive StcE
(Figure 5a,b). To further determine the impact of decreased mucuslevels on EHEC adherence to the biopsy epithelium, we removed the
mucus layer after the IVOC and quantified adherent EHEC by immuno-
fluorescence staining. As shown in Figure 5c, EHEC bacteria were pre-
dominantly attached to the intercrypt surface epithelium, and no
adhering bacteria were detected in non‐infected control samples.
Quantification of adherent bacteria revealed a significant decrease in
epithelial binding of EHEC ΔstcE compared to the wild‐type and
complemented strain (Figure 5d).3 | DISCUSSION
EHEC is a colonic pathogen which binds tightly to human intestinal
epithelium by forming A/E lesions (Lewis et al., 2015). To do so, the
bacteria must first interact with and penetrate the thick mucus layer
overlying the colonic epithelium (Johansson et al., 2014; McGuckin
et al., 2011). How this happens is still largely unknown due to a paucity
of suitable animal models (Ritchie, 2014). In addition, most human cell
line models used to study EHEC infection (e.g. T84, Caco‐2, and HT‐29
colon carcinoma cells) are devoid of a MUC2‐containing mucus layer
(Navabi, McGuckin, & Lindén 2013; van Klinken et al., 1996; Walsham
et al., 2016). Using goblet cell‐like LS174T colon carcinoma cells which
FIGURE 5 StcE diminishes the inner mucus layer and enhances EHEC adherence to human colonic biopsy epithelium. Tissue samples from the
transverse colon were infected with wild‐type TUV 93‐0 (wt), an stcE mutant (ΔstcE), ΔstcE complemented with wild‐type (comp), or
catalytically inactive StcE (inact), or left non‐infected (NI) for 8 hr. (a) Immunofluorescence staining of the inner mucus layer with anti‐MUC2 (red)
and counterstaining of cell nuclei with DAPI (blue). Shown are separate monochrome images of MUC2 staining and merged colour images of both
fluorescence channels (MUC2‐DAPI). Bar =50 μm. (b) Quantification of MUC2 staining by integrated density measurement. Means with different
letters are significantly different (p < 0.001). (c) Immunofluorescence staining of non‐infected (NI) and wild‐type EHEC‐infected biopsies (wt)
showing EHEC bacteria (red) and cell nuclei (blue). Shown are merged colour images of both fluorescence channels. c = crypt; bars = 20 μm. (d)
Quantification of adherent bacteria per mm2 surface area. ***p < 0.001, *p < 0.05. n = 4 in triplicate
HEWS ET AL. 5 of 10produce MUC2 glycoproteins (van Klinken et al., 1996), we found that
EHEC O157:H7 prototype strains adhered better to this cell line com-
pared to mucus‐deficient Caco‐2 and HT‐29 cells. A similar phenotype
has recently been reported for the related A/E pathogen enteropatho-
genic E. coli, which demonstrated increased binding to LS174T versus
HT‐29 cells (Walsham et al., 2016). In addition, adhesion of Salmonella
enterica to mucus‐producing HT‐29 MTX cells was significantly
increased compared to mucus‐deficient HT‐29 and Caco‐2 cells
(Gagnon, Zihler Berner, Chervet, Chassard, & Lacroix, 2013). Although
many different adhesins have been identified for EHEC, there is very
limited information on EHEC binding to mucus (McWilliams & Torres,
2014). Previous studies have shown binding of EHEC H7 flagella to
isolated bovine colonic mucus and mucin from bovine submaxillary
glands and porcine stomach (Erdem, Avelino, Xicohtencatl‐Cortes, &
Girón, 2007). Here, we showed increased adhesion of a fliC EHEC
deletion mutant to LS174T cells compared to the wild‐type strain. This
result may be explained by upregulation of other colonisation factors
in the fliC mutant as previously shown for Pseudomonas aeruginosa,
where deletion of flagellin resulted in induction of the type III secretionsystem (Soscia, Hachani, Bernadac, Filloux, & Bleves, 2007). Further-
more, deletion of long polar fimbriae enhanced EHEC adherence to
human intestinal explants suggesting cross talk between bacterial
adhesion systems (Fitzhenry et al., 2006). Alternatively, the lack of
motility associated with these mutants may lead to enhanced binding
or retention in the mucus layer (Rossez, Wolfson, Holmes, Gally, &
Holden, 2015). It was further noted that EHEC A/E lesion formation
in LS174T cells occurred earlier than in Caco‐2 cells, thereby explaining
the observed dependency on intimin for adherence to this cell line.
Whether enhanced EHEC binding and A/E lesion formation in
LS174T cells is ultimately linked to mucus production or associated
with expression of other cell surface receptors remains to be
established. In addition, the role of other EHEC adhesins in binding
to human intestinal mucus should be investigated.
In the second part of this study, we investigated the influence of
EHEC infection on mucus production. Previous reports on the murine
A/E pathogen Citrobacter rodentium demonstrated dynamic changes in
mucus thickness during infection (Gustafsson et al., 2013). During the
acute phase, mucin expression and goblet cell numbers were reduced
TABLE 1 Bacterial strains
Strain name Resistance Reference
TUV 93‐0 A. Donohue‐Rolfe, Tufts
University, US
TUV 93‐0 ΔfliC Kan Erdem et al., 2007
TUV 93‐0 ΔstcE Kan This study
TUV 93‐0 ΔstcE comp Kan, Cm This study
TUV 93‐0 ΔstcE inact Kan, Cm This study
85‐170 Tzipori et al., 1987
85‐170 Δeae Fitzhenry et al., 2002
85‐170 Δecp Kan Rendón et al., 2007
85‐170 ΔlpfA1 Cm Fitzhenry et al., 2006
6 of 10 HEWS ET AL.in the distal colon, and this was dependent on the host adaptive
immune response (Bergstrom et al., 2008; Lindén, Florin, & McGuckin,
2008). In contrast, increased mucus secretion at later stages of infec-
tion promoted expulsion of bacteria into the gut lumen and clearance
of infection (Bergstrom et al., 2010; Gustafsson et al., 2013). The pro-
tective role of the mucus layer during Citrobacter infection was further
demonstrated by studies in Muc2‐deficient mice, which exhibited
increased weight loss and mortality due to elevated pathogen burden
at the mucosal surface (Bergstrom et al., 2010). Similar to Citrobacter,
infection with atypical but not typical enteropathogenic E. coli
increased mucus production in rabbit ileal loops and mucin‐producing
HT‐29 MTX cells, which promoted bacterial growth in the absence of
luminal flow (Vieira et al., 2010).
Apart from MUC2, LS174T cells also secrete MUC5AC, which is
usually expressed in the stomach but also associated with colon cancer
(Bartman et al., 1999; van Klinken et al., 1996). In our studies, no
changes in MUC2 and MUC5AC gene expression were detected in
EHEC‐infected LS174T cells. This is in contrast to previous studies
demonstrating increased MUC2 gene expression in HT‐29 cells
infected with EHEC (Xue et al., 2014). This discrepancy is likely related
to the difference in cell line models, and as HT‐29 cells do not express
MUC2 glycoproteins (Huet et al., 1995; Walsham et al., 2016), the
relevance of this finding remains questionable.
In contrast to the gene expression results, MUC2 protein levels
were significantly decreased in EHEC‐infected LS174T cells. This is
in agreement with a recent study reporting reduction of the
MUC2‐containing inner mucus layer in EHEC‐infected colonic
organoids (In et al., 2016). One likely explanation for this phenotype
is the production of mucus‐degrading enzymes, which has been
reported in enteropathogens (McGuckin et al., 2011). Shigella flexneri
and enteroaggregative E. coli secrete the mucin‐degrading serine pro-
tease Pic (Henderson, Czeczulin, Eslava, Noriega, & Nataro, 1999), and
Vibrio cholerae produces the mucinolytic metalloproteases Hap and
TagA (Silva, Pham, & Benitez, 2003; Szabady, Yanta, Halladin, Schofield,
&Welch, 2011). Interestingly, the latter has high sequence homology to
the StcE zinc metalloprotease from EHEC, which is located on the
pO157 virulence plasmid and secreted by a type II secretion system
(Lathem et al., 2002). StcE has been shown to modulate the host
immune response by cleaving C1 esterase inhibitor and CD43 and
CD45 neutrophil glycoproteins (Lathem et al., 2002; Szabady, Lokuta,
Walters, Huttenlocher, & Welch, 2009) and also reduces the viscosity
of human saliva by degrading mucin 7 and glycoprotein 340 (Grys
et al., 2005). However, recombinant StcE did not show any activity
against purified human MUC2 (Grys, Walters, & Welch, 2006), and
infection of human colonic organoids with an stcEmutant only resulted
in a slight decrease in mucus reduction compared to the wild‐type
strain (In et al., 2016). Here, we found that deletion of stcE significantly
diminished reduction of mucin levels during EHEC infection of LS174T
cells. As catalytic inactivation of StcE had the same effect, it is likely that
StcE lowers mucin levels by MUC2 degradation. However, other mech-
anisms related to mucin glycoprotein synthesis and secretion cannot be
excluded at this stage. Diminished mucus reduction in ΔstcE‐infected
cells was accompanied by a decrease in A/E lesion formation despite
adhesion levels comparable to the wild‐type strain. Our findings con-
firm previous results in HEp‐2 cells demonstrating reduced actinpedestal formation but not overall adherence byΔstcE versus wild‐type
EHEC (Grys et al., 2005). HEp‐2 cells do not secrete a mucus layer, and
the authors suggested that StcE promotes intimate adherence by cleav-
ing cell surface mucins and thereby exposing host cell receptors. To
evaluate our findings in a physiologically relevant setting, we used
IVOC of human colonic biopsies to investigate the impact of StcE on
mucus production and EHEC adherence ex vivo. Previous studies from
our laboratory have shown that EHEC binds to human colonic biopsy
epithelium by forming A/E lesions (Lewis et al., 2015). Similar to our
results in LS174T cells, reduction of the inner MUC2‐containing mucus
layer in IVOC was dependent on the presence of catalytically active
StcE. However, lack of StcE caused a more pronounced effect on EHEC
binding than in the cell line model with an almost complete loss of
adherence to the colonic epithelium. It is likely that infection kinetics,
environmental cues or host response may fine‐tune expression and/
or activity of StcE and other EHEC mucinases, and this may explain
the differences in StcE‐mediated mucin reduction observed in IVOC
and colonic organoids (In et al., 2016).
Notably, some decrease in mucus levels independent of StcE was
evident in LS174T cells and colonic biopsies, suggesting the activity of
other mucinolytic enzymes during EHEC infection. Apart from StcE,
another type II‐secreted zinc metalloprotease has recently been identi-
fied in intestinal and extraintestinal E. coli strains (Nesta et al., 2014).
Although SslE facilitates mucus penetration of extraintestinal E. coli
in HT‐29 MTX cells and enhances bacterial adhesion to the epithelial
surface (Valeri et al., 2015), this protein is rarely detected in EHEC
and therefore unlikely to contribute to its pathogenesis (Feng et al.,
2007; Nesta et al., 2014).
In summary, our studies have shown that the EHEC‐secreted
metalloprotease StcE reduces mucus levels and promotes bacterial
adherence to human colonic epithelium in vitro and ex vivo. Given the
lack of effective prevention and treatment strategies, StcE may repre-
sent a suitable target for drug and vaccine development against EHEC
infection in the human gut.4 | Experimental procedures
4.1 | Bacterial culture
EHEC strains used in this study are listed inTable 1. Bacteria were cul-
tured on Luria‐Bertani (LB) agar or as standing overnight cultures in LB
HEWS ET AL. 7 of 10broth at 37 °C unless otherwise stated. Where indicated, mutant
strains were grown in the presence of 50 μg/ml kanamycin or 30 μg/
ml chloramphenicol (Table 1).4.2 | Cell culture
HT‐29 (ECACC 91072201), Caco‐2 (ECACC 86010202), and LS174T
human colon carcinoma cells (ECACC 87060401) were cultured in
Dulbecco's Modified Eagle's Medium (DMEM, Sigma) supplemented
with 10% foetal calf serum, 4mM L‐glutamine and 1× nonessential
amino acids (Sigma). Cell lines were grown at 37 °C in a 5% CO2
atmosphere.4.3 | Infection of cell lines
Cells were seeded at a density of 105 (LS174T, Caco‐2) or 1.2 × 105 cells
per well (HT‐29) into 24‐well plates and grown for 7 days to reach full
confluence. For immunofluorescence staining, cells were grown on glass
coverslips. For infection, supplemented DMEMwas replaced with plain
DMEM medium, and 20 μl bacterial overnight culture (approximately
107 bacteria) were added to each well. Infected cells were incubated at
37 °C in a 5% CO2 atmosphere for up to 6 hr. Medium was exchanged
after 3 hr to prevent bacterial overgrowth and acidification. At the end
of infection, cells were washed three times with phosphate‐buffered
saline (PBS) to remove non‐adherent bacteria and processed according
to further applications.4.4 | Quantification of adherence
Infected cells were lysed with 1% Triton X‐100 in PBS for 15 min. Cell
lysates were serially diluted in PBS, and appropriate dilutions were
plated on LB agar. Plates were incubated overnight, and colony‐
forming units were counted the next day.4.5 | IVOC of endoscopic biopsies
This study was performed with approval from the University of East
Anglia Faculty of Medicine and Health Ethics Committee (ref 2010/
11‐030). All samples were registered with the Norwich Biorepository
(NRES ref 08/h0304/85 + 5). Biopsy samples from the transverse
colon were obtained with informed consent during colonoscopy of
adult patients. Samples were taken from macroscopically normal areas,
transported to the laboratory in IVOC medium and processed within
the next hour. IVOC was performed as described previously (Lewis
et al., 2015). Briefly, biopsies were mounted on foam supports in 12‐
well plates and incubated with 25 μl bacterial overnight culture
(approximately 107 bacteria). Samples were incubated for 8 hr on a
rocking platform at 37 °C in a 5% CO2 atmosphere. At the end of
the experiment, tissues were either immediately fixed for mucin stain-
ing or washed vigorously in PBS to remove the mucus layer and eval-
uate bacterial adhesion to the epithelium.4.6 | Immunofluorescence staining
Cells and biopsy samples were fixed in 3.7% formaldehyde/PBS for
20 min at room temperature or in Carnoy's fixative (60% dry ethanol,30% chloroform, and 10% glacial acetic acid) overnight at 4 °C for
mucin staining. Samples were permeabilised with 0.1% Triton X‐100/
PBS if required and were blocked with 0.5% bovine serum albumine
(BSA)/PBS for 20 min. Coverslips and tissues were sequentially incu-
bated with primary antibodies (anti‐MUC2 and anti‐MUC5AC from
Santa Cruz, anti‐E. coli from Abcam) for 1 hr, followed by incubation
in Alexa Fluor 488‐ or Alexa Fluor 568‐conjugated secondary antibod-
ies (Life Technologies) for 30 min. Cell nuclei and filamentous actin
were counterstained with DAPI (Roche) and Fluorescein isothiocya-
nate‐conjugated phalloidin (Sigma) for 30 min, respectively. Cell mono-
layers and biopsy samples were mounted with Vectashield mounting
medium (Vector Labs) and analysed using an Axio Imager M2
motorised fluorescence microscope (Zeiss). MUC2 fluorescence stain-
ing was measured by taking images from 10 random fields of view (20×
magnification) and determining the integrated density with ImageJ
software (https://imagej.nih.gov/ij/). EHEC actin pedestal formation
on LS174T cells was quantified by taking images from 10 random fields
of view (63× magnification) and counting total bacteria and bacteria
associated with actin pedestals. EHEC colonisation of colonic biopsies
was evaluated by counting adherent bacteria in a surface area of
1 mm2.4.7 | SDS‐agarose gel electrophoresis and Western
blotting
Confluent LS174T cell monolayers were lysed in ice‐cold lysis buffer
(1% Triton X‐100, 20mMHEPES, 140mMNaCl, pH 7.4) containing pro-
tease inhibitor cocktail (Sigma). Triton‐insoluble proteins were pelleted
by centrifugation, and supernatants were denatured in reducing lithium
dodecyl sulfate sample buffer (Thermo Fisher Scientific). Mucin glyco-
proteins were separated by SDS‐agarose gel electrophoresis as
described previously (Warren, Krzesinski, & Greaser, 2003). Briefly, a
1cm 12% polyacrylamide plug was cast using 10 × 8cm glass plates
and 1.5mm spacers (Bio‐Rad). After polymerisation, this was overlaid
by a 1% agarose gel (Agarose LE, Promega) prepared in running buffer
(50mM Tris, 384mM glycine, and 0.1% SDS) containing 30% glycerol.
Samples were electrophoresed at 13 mA for 45 min at 4 °C in a Mini‐
PROTEAN Tetra Cell device (Bio‐Rad). For electroblotting, gels were
placed into NuPAGE transfer buffer (Thermo Fisher Scientific) contain-
ing 10%methanol and blotted to 0.45μmHybondPVDFmembrane (GE
Healthcare Life Sciences) at 40 V for 2 hr 20min at 4 °C in an Xcell II blot
module (Thermo Fisher Scientific). Membranes were subsequently
blocked with 3% BSA in Tris‐buffered saline/0.05% Tween‐20 for
60 min and incubated with mouse anti‐MUC2 (abcam) overnight at
4 °C. After washing, blots were incubated with horseradish peroxi-
dase‐conjugated goat anti‐mouse IgG (Invitrogen) and developed using
enhanced chemiluminescence (Immobilon Western, Millipore) and a
FluorChem E Imager (ProteinSimple). Signal intensity was quantified
using ImageJ software.4.8 | Bacterial mutagenesis and complementation
An stcE mutant in strain TUV 93‐0 was generated by Lambda Red
recombination (Datsenko & Wanner, 2000). Briefly, the helper plasmid
pKD46 carrying the Lambda Red recombinase was electroporated into
8 of 10 HEWS ET AL.TUV 93‐0, and recombinant bacteria were selected on LB agar con-
taining 100 μg/ml ampicillin. Subsequently, the kanamycin resistance
cassette from plasmid pKD4 was polymerase chain reaction (PCR)
amplified using Q5 High Fidelity DNA Polymerase (NEB) and primers
M1 (5′‐CCGATGAAATTAAAGTATCTGTCATGTACGATCCTTGCCCC-
TCTGGCGTGTAGGCTGGAGCTGCTTCG‐3′, Sigma‐Genosys) and M2
(5′‐CCTCATTGACCTAGGTTTACTGAAGTCCAAATACTGTCCCATAT-
GAATATCCT‐3′) flanking the resistance gene and including approxi-
mately 40 bp extensions complementary to stcE. The resulting PCR
product was electroporated into pKD46‐recombinant TUV 93‐0, and
Lambda Red recombinase expression was induced with 0.2% arabinose
(w/v). Recombinants were selected on LB plates containing 50 μg/mL
kanamycin, and clones were cured from pKD46 by incubation at
43 °C. Mutagenesis of stcE was confirmed by sequencing (Eurofins)
using primers M1 and M2 and external primers E1 (5′‐GCCCT-
GAAGCTTGCTGAACGCATCGGTG‐3′) and E2 (5′‐CCTGCGCTCTC-
CCCTCCGATGATAGTGG‐3′) flanking the site of mutation.
For complementation, the stcE gene and its promotor were PCR
amplified from the pO157 plasmid of TUV 93‐0 using primers stcE‐F
(5′‐CTCTGAGGTGTCTGTTAAACCCG‐3′) and stcE‐R (5′‐AAGTGGC-
CGCACCGTCTC‐3′). The PCR product was blunt end‐ligated into the
low copy‐number vector pACYC184 (NEB) digested with NruI (NEB)
to generate pACYC184‐stcE. Complementing plasmid with catalytically
inactive StcE E447D (Yu, Worrall, & Strynadka, 2012) was created by
PCR amplifying stcE from pACYC184‐stcE using primers pairs stcE‐F/
stcE_mut‐R (5′P‐TCATGACTGAACTCATTCCC‐3′) and stcE_mut‐F (5′
P‐TGTTGGTCATAATTATGGTCTTGG‐3′)/stcE‐R. The resulting
amplicons were mixed in equimolar amounts, ligated, and PCR ampli-
fied using primers stcE‐F and stcE‐R. Amplification products were sub-
sequently blunt‐end ligated into NruI‐restricted pACYC184 to
generate pACYC184‐stcEE447D. Plasmids were transformed into TUV
93‐0 ΔstcE by electroporation, and recombinant clones were selected
on LB agar containing 30 μg/ml chloramphenicol. Successful transfor-
mation was confirmed by PCR with primers stcE‐F and stcE‐R and
sequencing of the entire cloning region using primers stcE‐F, stcE‐R,
NruI‐F (5′‐CCACCAAACGTTTCGGCGAG‐3′), NruI‐R (5′‐TGCCTG-
GACAGCATGGCCTG‐3′), stcE‐F2 95′‐AAAAGTCTGCTGCTTGTC-
CG‐3′), stcE‐F3 (5′‐GGAATATTTCCAGACCATTCC‐3′) and stcE‐F4
(5′‐GTGGAATGCAGATACGCAGG‐3′).4.9 | Quantitative reverse transcription polymerase
chain reaction
Total cellular RNA was extracted using the Promega SV RNA extrac-
tion kit according to the manufacturer's instructions. RNA concentra-
tion and purity was determined using a NanoDrop ND‐1000
spectrophotometer (Fisher Scientific), and RNA integrity was con-
firmed by agarose gel electrophoresis. For cDNA synthesis, 1 μg
RNA was reverse‐transcribed using qScript cDNA supermix (Quanta
BioSciences). Quantitative PCR was carried out using SYBR Green
JumpStart Taq ReadyMix (Sigma) and an ABI7500 Taqman lightcycler
(Applied BioSciences). Primers were purchased from Sigma‐Genosys,
and the following sequences were used for amplification of mucin
(MUC2 and MUC5AC) and housekeeping genes (RNA polymerase II
polypeptide A‐POLR2A and tyrosine 3‐monooxygenase/tryptophan5‐monooxygenase activation protein, zeta polypeptide‐YWHAZ):
MUC2‐F 5′‐ACTGCACATTCTTCAGCTGC‐3′, MUC2‐R 5′‐ATTCAT-
GAGGACGGTCTTGG‐3′, MUC5AC‐F 5′‐CTGGGGTCCTCATTCAG-
CAG‐3′, MUC5AC‐R 5′‐CCCGAATTCCATGGGTGTCA‐3′, POLR2A‐F
5′‐GATGGGCAAAAGAGTGGACTT‐3′, POLR2A‐R 5′‐GGGTACTGA-
CTGTTCCCCCT‐3′, YWHAZ‐F 5′‐ACTTTTGGTACATTGTGGC-
TTCAA‐3′, and YWHAZ‐R 5′‐CCGCCAGGACAAACCAGTAT‐3′.
Cycling parameters were as follows: 2 min at 95 °C; 30 s at 95 °C,
30 s at 60°C, 35 s at 72°C (40 cycles); 5 min at 72°C. PCR product
specificity was confirmed by melt curve analysis and agarose gel elec-
trophoresis. Relative quantification of gene expression was performed
using the comparative cycle threshold (Ct) method. Ct values for genes
of interest were normalized using the geometric mean Ct of the two
housekeepers. Fold expression levels in treated samples were calcu-
lated relative to matched non‐treated controls using the formula
2−ΔΔCt.
4.10 | Statistics
All data are shown as means ± standard error of the mean of three inde-
pendent experiments performed in duplicate unless indicated other-
wise. Statistical analysis was performed using GraphPad Prism
software (version 5). Student's t test or one‐way analysis of variance
with Tukey's multiple comparisons test was used to determine differ-
ences between two or multiple groups, respectively. For biopsy data,
the nonparametric Kruskal‐Wallis test with Dunn's post‐test was used
to analyse multiple groups. A p value of <0.05 was considered
significant.
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